[Skip to Navigation]
Sign In
Comment & Response
February 24, 2022

Interpretation of the Efficacy of Multidisciplinary Geriatric Assessment Intervention on Chemotherapy-Related Toxic Effects in Older Adults With Cancer

Author Affiliations
  • 1Kyorin University Faculty of Medicine, Shinkawa, Tokyo, Japan
  • 2Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, Miyagi, Japan
  • 3Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan
JAMA Oncol. 2022;8(4):647. doi:10.1001/jamaoncol.2021.8064

To the Editor We congratulate Li et al for conducting a large-scale randomized clinical trial (RCT) evaluating geriatric assessment–driven intervention (GAIN) for older people with cancer.1 Because this study showed that GAIN significantly reduced the incidence of grade 3 or higher chemotherapy-related toxic effects, the results solidify the efficacy of the integration of multidisciplinary geriatric assessment (GA) intervention. However, as some other recent clinical trials have failed to show the efficacy of that,2,3 it is important to evaluate the results of this trial carefully. We thus have several concerns, especially regarding the study design.

Add or change institution